Alzamend Neuro
ALZN
20 hedge funds and large institutions have $3.13M invested in Alzamend Neuro in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 5 closing their positions.
1,140% more call options, than puts
Call options by funds: $62K | Put options by funds: $5K
16% more capital invested
Capital invested by funds: $2.7M → $3.13M (+$438K)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
17% less funds holding
Funds holding: 24 → 20 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IIC
Integrated Investment Consultants
Bloomfield Hills,
Michigan
|
+$23.5K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$3.13K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$3.13K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$1.57K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$26.6K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$15.4K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7.05K |
| 4 |
Jane Street
New York
|
-$5.1K |
| 5 |
CF
Centaurus Financial
Anaheim,
California
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Jane Street
New York
| – | -$5.1K | -9 | Closed |
|
27
Bank of America
Charlotte,
North Carolina
| – | -$112 | – | – |
|
ALZN Hedge Fund Activity: Q2 2023 in Review
20 of the 6,371 institutional investors tracked by Wall St. Rank reported a position in Alzamend Neuro (ALZN) for Q2 2023, worth a combined $3.13M — up 16% from $2.7M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ALZN and 1 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Integrated Investment Consultants, opening a new position worth an estimated $23.5K. The largest seller was Virtu Financial, cutting an estimated $26.6K.
- 20 institutional investors held Alzamend Neuro (ALZN) as of Q2 2023, down from 24 in Q1 2023.
- Funds reported $3.13M of Alzamend Neuro stock for Q2 2023, up 16% quarter-over-quarter.
- 1 fund opened new Alzamend Neuro positions in Q2 2023 and 5 closed out, a net change of -4 holders.
- The largest Alzamend Neuro buyer in Q2 2023 was Integrated Investment Consultants, an estimated $23.5K added.
- The largest Alzamend Neuro seller in Q2 2023 was Virtu Financial, an estimated $26.6K sold.
Based on aggregated 13F filings for Q2 2023.